| human | Q5 |
| P496 | ORCID iD | 0000-0002-3418-7518 |
| 0000-0002-8073-5028 | ||
| P1153 | Scopus author ID | 7003384579 |
| P1416 | affiliation | AB3C | Q113585840 |
| P69 | educated at | Faculty of Medicine of the University of Porto | Q10279533 |
| P108 | employer | Unidade Local de Saúde de Santo António | Q29525129 |
| Centro Hospitalar do Tâmega e Sousa | Q30263751 | ||
| P734 | family name | Vasconcelos | Q2511061 |
| Vasconcelos | Q2511061 | ||
| Vasconcelos | Q2511061 | ||
| P101 | field of work | bioinformatics | Q128570 |
| P735 | given name | Carlos | Q364753 |
| Carlos | Q364753 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q51289629 | 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. |
| Q54417738 | A 3'-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus. |
| Q38275580 | A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients |
| Q39019163 | A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). |
| Q38589244 | Alveolar hemorrhage in systemic lupus erythematosus: a cohort review |
| Q35893548 | Anti-ro52 antibodies and interstitial lung disease in connective tissue diseases excluding scleroderma |
| Q33341941 | Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients |
| Q48720686 | Are cognitive and olfactory dysfunctions in neuropsychiatric lupus erythematosus dependent on anxiety or depression? |
| Q34409787 | Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial |
| Q43736626 | Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells |
| Q54688004 | CCR5-Delta32: implications in SLE development. |
| Q34435380 | Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients |
| Q30362877 | Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital |
| Q40915108 | Characteristics of Neuro-Behçet's Disease in a Case-Series from a Single Centre in Northern Portugal |
| Q43275862 | Cognitive functioning in Behçet's disease |
| Q34221885 | Compensatory T-cell regulation in unaffected relatives of SLE patients, and opposite IL-2/CD25-mediated effects suggested by coreferentiality modeling |
| Q39188717 | Complement C3 as a marker of cardiometabolic risk in psoriasis |
| Q39844684 | Development and use of touch - screen computer-assisted self interviewing in Portuguese patients with chronic immune diseases: evaluation of an electronic version of sf-36v2 . |
| Q53008611 | Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study. |
| Q40339447 | Digital ulcers in systemic sclerosis: role of flow-mediated dilatation and capillaroscopy as risk assessment tools |
| Q84565405 | Do we need autoimmune disease units in hospitals? |
| Q45184210 | Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial |
| Q57526166 | Epicardial adipose tissue and coronary artery calcification in psoriasis patients |
| Q59380704 | Epidemiology of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Colonization Among Patients and Healthcare Workers in a Portuguese Hospital: A Pre-intervention Study Toward the Control of MRSA |
| Q37391863 | European consensus statement on the terminology used in the management of lupus glomerulonephritis |
| Q39389089 | Evaluation of the reactivity of sera from patients with systemic lupus erythematosus against the human MCP1. |
| Q47618195 | Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus |
| Q37971294 | Fetal outcome in autoimmune diseases. |
| Q42099090 | Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein |
| Q46275708 | Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease |
| Q43629235 | Frequent involvement of central nervous system in primary Sjögren syndrome |
| Q36806427 | Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. |
| Q34803158 | Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus |
| Q60991286 | HIV encephalitis in chronic infection: An acute presentation |
| Q54465103 | HLA in Portuguese systemic lupus erythematosus patients and their relation to clinical features. |
| Q44900434 | Health related quality of life of chronic patients with immune system diseases: a pilot study |
| Q37660750 | Hemophagocytic syndrome as one of the main primary manifestations in acute systemic lupus erythematosus--case report and literature review |
| Q57526263 | Heritable factors shape natural human IgM reactivity to Ro60/SS-A and may predispose for SLE-associated IgG anti-Ro and anti-La autoantibody production |
| Q43993205 | Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide |
| Q40355666 | Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis |
| Q57526172 | Influence of TNF-α gene polymorphisms in coronary artery calcification in psoriasis patients |
| Q38095888 | Is there a cure for systemic lupus erythematosus? |
| Q36302245 | Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis |
| Q53448478 | Lack of association between leptin, leptin receptor, adiponectin gene polymorphisms and epicardial adipose tissue, abdominal visceral fat volume and atherosclerotic burden in psoriasis patients. |
| Q73063639 | Lessons from the "Euro-Lupus Cohort" |
| Q53096105 | Levels of physical activity in patients with severe psoriasis: a cross-sectional questionnaire study. |
| Q36681801 | Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis |
| Q33403373 | Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants |
| Q37292556 | Lucky to meet RS3PE. |
| Q34543175 | Lupus nephritis: a retrospective review of 78 cases from a single center. |
| Q33412915 | Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients |
| Q43519903 | Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients |
| Q53189383 | Networking in Europe for special centres of excellence for autoimmune diseases. |
| Q40231273 | Neurological involvement in Primary Sjögren Syndrome |
| Q57526240 | New insights of HLA class I association to Behçet’s disease in Portuguese patients |
| Q55536008 | PReS-FINAL-2122: Autologous stem cell transplantation in a patient with severe systemic sclerosis in Portugal. |
| Q40302527 | Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients |
| Q37551634 | Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution |
| Q47749372 | Primary nasal tuberculosis during anti-tumour necrosis factor alpha treatment of a patient with rheumatoid arthritis |
| Q26314483 | Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016 |
| Q44794489 | Psoriasis and cardiovascular disease |
| Q38554808 | Quality of life in systemic sclerosis |
| Q84162157 | Refractory disease in autoimmune diseases |
| Q37877824 | Refractory disease in systemic lupus erythematosus. |
| Q34081240 | Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial |
| Q36399103 | Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". |
| Q37875936 | Systemic sclerosis refractory disease: from the skin to the heart. |
| Q38601631 | T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review |
| Q33401164 | The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide |
| Q91715504 | The Impact of a Community-Based Food Education Program on Nutrition-Related Knowledge in Middle-Aged and Older Patients with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial |
| Q36271927 | The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases |
| Q73390933 | The family physician and the human immunodeficiency virus seropositive patient |
| Q38377131 | The role of infections in Behçet disease and neuro-Behçet syndrome |
| Q87408350 | Therapeutic resistance in autoimmune diseases |
| Q39147436 | Topics on vitamin D in systemic lupus erythematosus: analysis of evidence and critical literature review |
| Q38676110 | Transancestral mapping and genetic load in systemic lupus erythematosus |
| Q41247616 | Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives |
| Q74448215 | [Uveitis] |
Search more.